期刊
PATHOLOGY RESEARCH AND PRACTICE
卷 210, 期 8, 页码 465-472出版社
ELSEVIER GMBH
DOI: 10.1016/j.prp.2014.06.003
关键词
Glitazones; Cancer; Pioglitazone; Bladder cancer
类别
资金
- Grant Science Agency - VEGA, Ministry of Education, Slovak Republic [1/0153/13]
Diabetes increases cancer risk, which may be modulated by careful choice of treatment. Experimental reports showed efficacy of glitazones in various in vitro and in vivo models of carcinogenesis, but procarcinogenic effects in some models were reported too, and, similarly, data on cancer incidence in glitazone users are inconsistent. This review summarizes oncostatic effects of glitazones in preclinical and clinical studies and brings a brief summary of their impact on cancer risk in diabetic patients, with a focus on the association between pioglitazone use and bladder cancer. (C) 2014 Elsevier GmbH. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据